Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May 11;15(5):963.
doi: 10.3390/ijerph15050963.

Protective Effects of Selected Botanical Agents on Bone

Affiliations
Review

Protective Effects of Selected Botanical Agents on Bone

James Jam Jolly et al. Int J Environ Res Public Health. .

Abstract

Osteoporosis is a serious health problem affecting more than 200 million elderly people worldwide. The early symptoms of this disease are hardly detectable. It causes progressive bone loss, which ultimately renders the patients susceptible to fractures. Osteoporosis must be prevented because the associated fragility fractures result in high morbidity, mortality, and healthcare costs. Many plants used in herbal medicine contain bioactive compounds possessing skeletal protective effects. This paper explores the anti-osteoporotic properties of selected herbal plants, including their actions on osteoblasts (bone forming cells), osteoclasts (bone resorbing cells), and bone remodelling. Some of the herbal plant families included in this review are Berberidaceae, Fabaceae, Arecaceae, Labiatae, Simaroubaceaea, and Myrsinaceae. Their active constituents, mechanisms of action, and pharmaceutical applications were discussed. The literature shows that very few herbal plants have undergone human clinical trials to evaluate their pharmacological effects on bone to date. Therefore, more intensive research should be performed on these plants to validate their anti-osteoporotic properties so that they can complement the currently available conventional drugs in the battle against osteoporosis.

Keywords: bone remodelling; complementary therapies; herbal medicine; osteoblast; osteoclast.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
The role of botanical bioactive compounds in regulating bone metabolism. They may act directly on the bone cells, or through reducing inflammation and oxidative stress, or indirectly via increasing the level of sex hormones and interacting with sex hormone receptors on bone cells.

References

    1. Lama A., Santoro A., Corrado B., Pirozzi C., Paciello O., Pagano T.B., Russo S., Calignano A., Mattace Raso G., Meli R. Extracorporeal shock waves alone or combined with raloxifene promote bone formation and suppress resorption in ovariectomized rats. PLoS ONE. 2017;12:e0171276. doi: 10.1371/journal.pone.0171276. - DOI - PMC - PubMed
    1. Sucuoglu H., Koyuncu H. Distribution of male osteoporosis patients according to age, classification, and fracture. Istanb. Med. J. 2017;18:13–17. doi: 10.5152/imj.2016.26234. - DOI
    1. Poole K.E.S., Skingle L., Gee A.H., Turmezei T.D., Johannesdottir F., Blesic K., Rose C., Vindlacheruvu M., Donell S., Vaculik J., et al. Focal osteoporosis defects play a key role in hip fracture. Bone. 2017;94:124–134. doi: 10.1016/j.bone.2016.10.020. - DOI - PMC - PubMed
    1. Iseme R.A., Mcevoy M., Kelly B., Agnew L., Walker F.R., Attia J. Is osteoporosis an autoimmune mediated disorder? Bone Rep. 2017:121–131. doi: 10.1016/j.bonr.2017.10.003. - DOI - PMC - PubMed
    1. Eastell R., Christiansen C., Grauer A., Kutilek S., Libanati C., McClung M.R., Reid I.R., Resch H., Siris E., Uebelhart D. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis. J. Bone Miner. Res. 2011;26:530–537. doi: 10.1002/jbmr.251. - DOI - PubMed

Publication types

LinkOut - more resources